Join our daily newsletter At The Bell to receive exclusive market insights
- Universal Biosensors (UBI) launches its acetic acid biosensor test on the Sentia wine testing platform
- This marks the fifth test available on the platform, with “ideal” timing for the upcoming fermentation and maturation period for northern hemisphere wineries
- The company says the tests are a “more compelling alternative” for winemakers compared to the more expensive, time-consuming, and often less accurate lab equipment and chemistries currently in use
- Additionally, the company says two further Sentia products are currently in development
- Universal Biosensors is down 3.17 per cent, trading at 30.5 cents at 1:08 pm AEDT
Universal Biosensors (UBI) has launched its acetic acid biosensor test on the Sentia wine testing platform.
This marks the fifth test now available on the platform, with the timing of the launch “ideal” for the upcoming fermentation and maturation period for wineries in the northern hemisphere.
The company says the tests are a “more compelling alternative” for winemakers compared to the more expensive, time-consuming, and often less accurate laboratory equipment and chemistries currently in use.
The acetic acid of wine is tested continuously throughout the year due to acidity being an important component of a wine’s quality and taste, adding a “sharpness” to the flavours. High levels of acetic acid in wine are considered a “highly undesirable fault”, according to UBI, and, therefore, monitoring is extremely important.
UBI CEO John Sharman said the launch of the new acetic acid test was another milestone for the Sentia platform.
“We have two more Sentia products in development, being a Titratable Acidity test and our next generation Free SO2 test, which will be a significant enhancement for the very good Free SO2 product already in market,” Mr Sharman said.
“Both products are scheduled for launch within the next two months.”
Universal Biosensors was down 3.17 per cent and trading at 30.5 cents at 1:08 pm AEDT.
